Why Is MYRIAD GENETICS INC (MYGN) Stock Moving Today?
MYRIAD GENETICS INC (MYGN) is drawing unusual attention today. Our newswire has captured 12 stories on MYGN across 8 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100).
The written analysis for MYGN publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.
MYGN by the numbers
The headlines behind the move
TD Cowen holds Myriad Genetics stock rating on Labcorp sale
TD Cowen holds Myriad Genetics stock rating on Labcorp sale
Myriad Genetics upgraded to Neutral from Underweight at Piper Sandler
Myriad Genetics stock surges on $210M prenatal unit sale
Myriad Genetics stock surges on $210M prenatal unit sale
MYGN jumps as Myriad agrees to sell Prenatal Health testing business to Labcorp for $210 million cash
Myriad Genetics (MYGN) announced a definitive agreement to sell its Prenatal Health testing business to Labcorp for $210 million in cash, plus the value of inventory at closing. Myriad said the deal is expected to be accretive to revenue growth and profitability while strengthening its balance sheet, and Labcorp expects about $160 million of year-one revenue and improving diagnostics margins by year two.
Myriad Genetics strikes $210 million prenatal testing divestiture to sharpen focus on cancer care priorities October 20, 2026
Myriad Genetics announced a definitive agreement to sell its Prenatal Health testing business to Labcorp for $210 million in cash plus inventory value at closing, a move Myriad says will strengthen its balance sheet and support investment in the cancer care continuum. Labcorp expects the acquisition to add about $160 million in year-one revenue, be slightly accretive to adjusted earnings in year one, and reach average diagnostics segment margins by the end of year two.
Myriad to sell prenatal health testing business to Labcorp for $210M
Myriad Genetics (MYGN) stock jumps as the company sells its Prenatal Health testing unit to Labcorp in an all-cash deal worth more than $210M. Read more here.
Why is Myriad Genetics stock surging today?
Why is Myriad Genetics stock surging today?
Myriad Genetics to Divest Prenatal Testing Business
Myriad Genetics ( ($MYGN) ) has shared an update. On October 19–20, 2026, Myriad Genetics and Labcorp announced a definitive agreement under which Myriad will sell ...
Myriad Genetics to sell Prenatal Health testing business to Labcorp
Frequently asked questions
Why is MYGN stock moving today?
MYRIAD GENETICS INC (MYGN) is drawing unusual attention today. Our newswire has captured 12 stories on MYGN across 8 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100). The most recent driver: "TD says Myriad Genetics prenatal divestiture proceeds ahead of expectations" (The Fly).
Is MYGN a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of MYGN coverage reads 60/100 over 12 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More moves explained today
- Why is BRZE up today (+51.50%)
- Why is LION up today (+15.70%)
- Why is KVYO up today (+12.24%)
- Why is FRNM up today (+11.50%)
- Why is RUN up today (+11.01%)
- Why is NWCL down today (-10.95%)
More on MYGN: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.